Internal Fixation Systems Gains 510(k) Approval

Internal Fixation Systems has received 510(k) clearance from the FDA to market subtalar implants. These implants are used to preserve motion at the ankle joint and to treat both trauma conditions and arthritis.

IFS CEO, Stephen Dresnick, MD, states that, "this approval allows us to continue to fill out our portfolio, and gives us another product for surgeons who use our products."

IFS currently offers a full line of mini-cannulated screws for small bone fixation as well as a Modular Locking Small Fragment System for treatment of bone fractures and osteotomies.

About IFS
Internal Fixation Systems Inc. is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants. We seek to prove that superior products and lower costs can go hand in hand. IFS focuses on widely used, market proven products used to treat common fractures. Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs. The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition. IFS customers include ambulatory surgery centers, hospitals, and orthopedic surgeons.